Business & Investment

Point72 Asset Management is Tricida, Inc. Increased the stock of. ByInvesting.com

© Reuters. Point72 Asset Management is Tricida, Inc. Increased the stock of.

On March 23, Point72 Asset Management purchased 1.3 million Trisida , Inc. (NASDAQ :) holds $ 6.6 million in shares at an average price of $ 5.01 per share. Tricida, Inc. Shares have fallen -5.39% since the transaction.

Tricida, Inc. The holding of Point 72 Asset Management at Point increased to approximately 2.5 million shares due to the purchase.

Point72 Asset Management will be available at Tricida, Inc. in the fourth quarter of 2018. I bought the stock of. Point72AssetManagement is AstraZeneca PLC ADR (NASDAQ :), Merck (MRK), Eli Lilly & Co (NYSE :), Chinook Therapeutics, Inc. (KDNY). Tricida, Inc. Is 39th in the number of shares and market value of biotechnology and life sciences stocks.

Tricida, Inc. For other investors who have added shares in Citigroup (NYSE :) and Millennium Management. In contrast, T. Low Price Equity Income Fund and Square Point Ops reduced TCDA shares.

Point72 Asset Management has recently been VYNE Therapeutics INC (VYNE) and MacroGenics, Inc. We also reduced our share on (NASDAQ :). The total amount of shares sold is estimated to be approximately $ 53 million.

In addition, Point72 Asset Management is CytomX Therapeutics, Inc. (NASDAQ :) and AnaptysBio, Inc. Established a new holding in (NASDAQ :). Point72 Asset Management has also been added to the share of Affimed NV (NASDAQ :). Cadomon Holdings Inc (NASDAQ :), Bicycle Therapeutics plc (NASDAQ :), Mereo BioPharma Group plc (MREO). The total amount of shares purchased is estimated to be approximately $ 123 million.

Point72 Asset Management is Syros Pharmaceuticals, Inc. We also reduced the share of (NASDAQ :). American Eagle Outfitters Inc (NYSE :), Childrens Place Inc (PLCE), Cell dynamics Inc (NASDAQ :), ANGI Homeservices Inc (NASDAQ :), Dave & Busters Entertainment Inc (NASDAQ :), Otonomy, Inc. (NASDAQ :), Calithera Biosciences, Inc. (CALA), Chiasma Inc (NASDAQ :) and Fulcrum Therapeutics, Inc. (NASDAQ :). The total amount of shares sold is estimated to be approximately $ 58 million.

In addition, Point72 Asset Management includes Curis Inc (CRIS), Miragen Therapeutics Inc (NASDAQ :), Aeglea BioTherapeutics, Inc. (AGLE), Hims & Hers Health, Inc. (HIMS) and Paya Holdings Inc. (PAYA) have established new holding companies. ). Point72 Asset Management has also been added to the share Alliance data system Corp (NYSE :), BioCryst (NASDAQ :) Pharmaceuticals Inc (BCRX), BGC partner Inc (NASDAQ :), Revolve group Inc (NYSE :) and Acorda Therapeutics Inc (NASDAQ :). The total amount of shares purchased is estimated to be approximately $ 270 million.

Disclaimer: Fusion media We inform you that the data contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indexes, futures) and forex prices are provided by the market maker, not the exchange, so prices may not be accurate and may differ from actual market prices. In other words, price is an indicator and is not suitable for trading purposes. Therefore, Fusion Media is not responsible for any transactional losses that may occur as a result of using this data.

Fusion media Alternatively, anyone involved in Fusion Media will not be liable for any loss or damage resulting from relying on the data, quotes, charts, trading signals and other information contained on this website. Please be fully informed about the risks and costs associated with trading in financial markets. This is one of the most risky forms of investment possible.



Point72 Asset Management is Tricida, Inc. Increased the stock of. ByInvesting.com

https://www.investing.com/news/stock-market-news/point72-asset-management-increased-stake-in-tricida-inc-2464897 Point72 Asset Management is Tricida, Inc. Increased the stock of. ByInvesting.com

Back to top button